News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Yocca Frank
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 521 restricted stock units
@ $0 |
|
| 03/16/2023 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 985 shares
@ $19.6911, valued at
$19.4k
Exercised 2,084 restricted stock units
@ $0
Granted 9,000 restricted stock units
@ $0
Granted 32,000 options to buy
@ $19.6, valued at
$627.2k
|
|
| 01/24/2023 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 50,000 shares
@ $30, valued at
$1.5M
|
|
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $41.17, valued at
$905.7k
|
|
| 03/17/2021 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 14,370 shares
@ $48.47, valued at
$696.5k
Sold 630 shares
@ $49.3, valued at
$31.1k
|
|
| 02/18/2021 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Sold 1,300 shares
@ $55.88, valued at
$72.6k
Sold 6,805 shares
@ $56.49, valued at
$384.4k
Sold 1,137 shares
@ $57.71, valued at
$65.6k
Sold 2,886 shares
@ $58.54, valued at
$168.9k
Sold 500 shares
@ $59.46, valued at
$29.7k
Sold 1,772 shares
@ $60.43, valued at
$107.1k
Sold 600 shares
@ $61.2, valued at
$36.7k
|
|
| 01/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2020 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $45.99, valued at
$2.1M
|
|
| 02/19/2020 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Exercised 80,000 options
@ $0.41, valued at
$32.8k
|
|
| 08/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 450 shares
@ $5.2299, valued at
$2.4k
Bought 450 shares
@ $5.1973, valued at
$2.3k
|
|
| 11/30/2018 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 450 shares
@ $5.199, valued at
$2.3k
|
|
| 11/30/2018 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $5.0223, valued at
$2.5k
|
|
| 03/13/2018 |
4
| Yocca Frank (Chief Scientific Officer) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 36,498 options
@ $11, valued at
$401.5k
|
|
| 03/07/2018 |
3
| Yocca Frank (Chief Scientific Officer) has filed a Form 3 on BioXcel Therapeutics, Inc. |
|
|